Medical Assisting School EBITDA Multiples: 2.5x–4.5x — What Buyers Pay (2026)
Accreditation status, Title IV eligibility, and enrollment stability are the primary value drivers separating a 2.5x deal from a 4.5x premium exit.
Medical assisting schools typically sell for 2.5x–4.5x EBITDA, with value anchored to accreditation standing, placement rates, and enrollment trends. CAAHEP or ABHES accreditation creates meaningful barriers to entry, supporting premium multiples for clean programs with stable cohorts and documented graduate outcomes.
Medical Assisting School EBITDA Multiples (2026)
| Practice Size | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Distressed / Accreditor Risk | $150K–$300K | 2.5x–3.0x | Active corrective action plans, declining enrollment, or probationary accreditor status significantly compress buyer interest and financing options. |
| Stable Independent Operator | $250K–$500K | 3.0x–3.5x | Clean accreditation history, steady enrollment, but owner-dependent operations or single-program offerings limit scalability premium. |
| Strong Regional Program | $400K–$700K | 3.5x–4.0x | 85%+ placement rates, multiple program offerings, written externship agreements, and a qualified director of education independent of the owner. |
| Premium Platform Asset | $600K–$1.2M | 4.0x–4.5x | Multi-program allied health curriculum, hybrid delivery capability, clean Title IV history, and enrollment growth attract PE-backed education platforms. |
Valuation Drivers — What Makes Your Multiple Higher or Lower
The spread between 3.5x and 6.5x is not random. These seven factors determine where your firm lands.
Accreditation Status
High Positive / NegativeUninterrupted CAAHEP or ABHES accreditation with no probationary history commands premium multiples. Active corrective action plans can kill deals or force price concessions of 0.5x–1.0x.
Title IV Eligibility
High PositiveActive Title IV participation expands the student financing pool and buyer universe. Change-of-ownership review risk must be managed carefully to avoid aid suspension during transition.
Graduate Placement Rates
Moderate to High PositiveDocumented placement rates above 85% with verifiable employer relationships satisfy accreditor standards and signal program quality to buyers underwriting future enrollment.
Owner Dependency
High NegativeOwners serving as sole director of education or primary externship contact create key-person risk. Buyers discount aggressively or require extended earnouts when operations cannot run independently.
Program Diversification
Moderate PositiveSchools offering phlebotomy, EKG, or medical billing alongside core medical assisting reduce single-cohort revenue risk and support higher multiples from platform-minded buyers.
Recent Market Trends
Demand for allied health workers remains strong through 2032, sustaining buyer interest in accredited programs. PE-backed education platforms are increasingly active acquirers seeking bolt-on opportunities, compressing cap rates for clean assets. Gainful employment rule enforcement and accreditor change-of-ownership friction continue to create transaction complexity for Title IV-dependent schools.
Who Buys Medical Assisting Schools in 2026
Individual Operator / Search Fund
Entrepreneurship through acquisition (ETA), first-time buyers, industry-adjacent operators
What they want: Stable, transferable cash flow in a Medical Assisting School. SBA-eligible business, strong accreditation status, and a seller available for a 12–18 month transition.
Pros for seller
- +SBA 7(a) financing means 10% buyer equity — faster than waiting for institutional capital
- +Buyer works inside the business, maintaining client and staff relationships
- +Deal structure is typically straightforward: cash at close plus seller note
Cons for seller
- −Lower multiples than PE buyers — typically at the low-to-mid end of the range
- −Requires meaningful seller involvement post-close for transition
- −SBA approval timeline adds 60–90 days to closing
PE-Backed Roll-Up Platform
Private equity consolidators building a Medical Assisting School portfolio, regional or national platforms
What they want: Scale, operational quality, and geographic coverage. Strong accreditation status with minimal accreditation status. Clean financials, documented systems, and staff who can operate without the selling owner.
Pros for seller
- +All-cash close with no SBA financing contingency or approval delay
- +Highest multiples available for premium businesses
- +Equity rollover option — seller keeps 10–30% stake and participates in platform exit
Cons for seller
- −Extensive 90–150 day due diligence process
- −Post-close integration into a larger platform changes operating culture
- −Usually requires seller to remain in a leadership role for 12–24 months
Strategic Acquirer
Larger Medical Assisting School operators, adjacent-industry buyers adding capacity or geography
What they want: Client relationships, staff, and market position that complement existing operations. Accreditation Status is especially valuable when it fills a gap the buyer cannot build organically.
Pros for seller
- +Can pay above-model multiples for strong strategic fit
- +Buyer already understands the business — diligence moves faster
- +Shorter transition requirement when operational overlap exists
Cons for seller
- −Fewer competing buyers — less negotiating leverage
- −Non-compete scope is typically broader than PE or individual deals
- −Operations and brand may change significantly post-close
Sample Medical Assisting School Transactions
Single-location ABHES-accredited medical assisting school in the Southeast; stable 3-year enrollment, 87% placement rate, owner transitioning out of instruction role.
$380K
EBITDA
3.6x
Multiple
$1.37M
Price
Multi-program allied health school (MA, phlebotomy, EKG) in the Midwest with hybrid delivery, clean Title IV history, and a credentialed director of education on staff.
$620K
EBITDA
4.2x
Multiple
$2.60M
Price
Owner-operated CAAHEP-accredited program with declining enrollment over two years, owner as sole instructor, no written externship agreements; sold at discount.
$210K
EBITDA
2.7x
Multiple
$567K
Price
EBITDA Valuation Estimator
Get your Medical Assisting School business value range instantly
Industry: Medical Assisting School · Multiples based on 3.0x–3.5x (Stable Independent Operator)
Powered by DealFlow OS
dealflow-os.com · Free M&A tools for every stage of the deal
How to Use These Multiples
For Sellers: 4-Step Valuation Walkthrough
- 1
Compile three years of P&L statements and tax returns that reconcile line by line — SBA lenders and institutional buyers both require this, and any unexplained gap triggers diligence delays or price renegotiation.
- 2
Build a normalized EBITDA schedule with every add-back documented: owner W-2 above a market-rate manager salary, personal expenses, one-time items, and non-recurring costs. Undocumented add-backs get cut.
- 3
Address your accreditation status before going to market — this is the most common reason Medical Assisting School businesses receive offers at the low end of the 2.5x–4.5x range. Buyers identify it in diligence and reprice accordingly.
- 4
Quantify and document your accreditation status with supporting records: contracts, renewal histories, and client revenue breakdowns. This is the primary evidence for commanding a premium multiple — have it ready before the first buyer call.
For Buyers: Validate the Asking Multiple
- 1
Request trailing 12-month and 3-year P&L with bank statement backup before making an offer. If a Medical Assisting School seller cannot produce reconciled financials, that signals what the full diligence process will look like.
- 2
Verify the accreditation status claims independently — pull contract copies, renewal documentation, and client-level revenue data. This is the primary driver of whether this Medical Assisting School is worth 4.5x or 2.5x.
- 3
Assess accreditation status directly: ask which revenue or client relationships depend on the current owner personally, and what the transition plan is. An exit-ready seller has already worked through this.
- 4
Model your SBA debt service against verified EBITDA before signing the LOI. At current rates, a $1M SBA 7(a) loan runs approximately $13,000/month over 10 years — the business needs at least 1.25x debt service coverage after a market-rate manager salary.
Frequently Asked Questions
How does accreditor change-of-ownership affect deal timing and valuation?
CAAHEP and ABHES require pre-approval or notification before ownership transfers. This process can take 3–12 months, often requiring escrow arrangements or earnout structures to protect both parties during review.
Can SBA financing be used to acquire a medical assisting school?
Yes. SBA 7(a) loans are commonly used for accredited medical assisting school acquisitions. Lenders typically require 10–15% buyer equity, clean accreditation history, and stable enrollment to approve financing.
What EBITDA margin should a medical assisting school have to attract buyers?
Buyers target EBITDA margins of 15–25%. Schools below 15% raise cost-structure concerns, while those above 25% with documented enrollment stability attract competitive offers from platform acquirers.
Does Title IV eligibility increase or decrease my school's sale value?
Active Title IV participation generally increases value by expanding student financing access, but introduces DOE audit risk and change-of-ownership compliance complexity that buyers will underwrite carefully.
More Medical Assisting School Guides
Related Reading
Find Medical Assisting School businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
No credit card required